Skip to main content
SpringerLink
Log in

Engineering Extracellular Vesicles for Cancer Therapy

  • Chapter
  • First Online:
New Frontiers: Extracellular Vesicles

Part of the book series: Subcellular Biochemistry ((SCBI,volume 97))

Abstract

Extracellular vesicles (EVs) are lipid bilayer containing nanovesicles that have a predominant role in intercellular communication and cargo delivery. EVs have recently been used as a means for drug delivery and have been depicted to elicit no or minimal immune response in vivo. The stability, biocompatibility and manipulatable tumour homing capabilities of these biological vessels make them an attractive target for the packaging and delivery of drugs and molecules to treat various diseases including cancer. The following chapter will summarise current EV engineering techniques for the purpose of delivering putative drugs and therapeutic molecules for the treatment of cancer. The relevance of EV source will be discussed, as well as the specific modifications required to manufacture them into suitable vehicles for molecular drug delivery. Furthermore, methods of EV cargo encapsulation will be evaluated with emphasis on intercellular coordination to allow for the effective emptying of therapeutic contents into target cells. While EVs possess properties making them naturally suitable nanocarriers for drugs and molecules, many challenges with clinical translation of EV-based platforms remain. These issues need to be addressed in order to harness the true potential of the EV-based therapeutic avenue.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Agrawal AK, Aqil F, Jeyabalan J, Spencer WA, Beck J, Gachuki BW, Alhakeem SS, Oben K, Munagala R, Bondada S, Gupta RC (2017) Milk-derived exosomes for oral delivery of paclitaxel. Nanomedicine 13(5):1627–1636

    Article  CAS  PubMed  Google Scholar 

  • Anand S, Samuel M, Kumar S, Mathivanan S (2019) Ticket to a bubble ride: cargo sorting into exosomes and extracellular vesicles. Biochim Biophys Acta Proteins Proteom. https://doi.org/10.1016/j.bbapap.2019.02.005

  • Andrews WD (2000 [cited 2016 Oct 20]) Pilot immunotherapy trial for recurrent malignant gliomas. Thomas Jefferson University. National Library of Medicine (US), Bethesda, MD

    Google Scholar 

  • Aqil F, Jeyabalan J, Agrawal AK, Kyakulaga AH, Munagala R, Parker L, Gupta RC (2017a) Exosomal delivery of berry anthocyanidins for the management of ovarian cancer. Food Funct 8(11):4100–4107

    Article  CAS  PubMed  Google Scholar 

  • Aqil F, Munagala R, Jeyabalan J, Agrawal AK, Gupta R (2017b) Exosomes for the enhanced tissue bioavailability and efficacy of curcumin. AAPS J 19(6):1691–1702

    Article  CAS  PubMed  Google Scholar 

  • Arms L, Smith DW, Flynn J, Palmer W, Martin A, Woldu A, Hua S (2018) Advantages and limitations of current techniques for analyzing the biodistribution of nanoparticles. Front Pharmacol 9:802

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Aspe JR, Diaz Osterman CJ, Jutzy JM, Deshields S, Whang S, Wall NR (2014) Enhancement of gemcitabine sensitivity in pancreatic adenocarcinoma by novel exosome-mediated delivery of the Survivin-T34A mutant. J Extracell Vesicles 3

    Google Scholar 

  • Batrakova EV, Kim MS (2015) Using exosomes, naturally-equipped nanocarriers, for drug delivery. J Control Release 219:396–405

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Baxter AA, Phan TK, Hanssen E, Liem M, Hulett MD, Mathivanan S, Poon IKH (2019) Analysis of extracellular vesicles generated from monocytes under conditions of lytic cell death. Sci Rep 9(1):7538

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Benameur T, Chappard D, Fioleau E, Andriantsitohaina R, Martinez MC, Clere N, Marchand-Libouban H (2013) Plasma cells release membrane microparticles in a mouse model of multiple myeloma. Micron 54–55:75–81

    Article  PubMed  CAS  Google Scholar 

  • Besse B, Charrier M, Lapierre V, Dansin E, Lantz O, Planchard D, Le Chevalier T, Livartoski A, Barlesi F, Laplanche A, Ploix S, Vimond N, Peguillet I, Thery C, Lacroix L, Zoernig I, Dhodapkar K, Dhodapkar M, Viaud S, Soria JC, Reiners KS, Pogge von Strandmann E, Vely F, Rusakiewicz S, Eggermont A, Pitt JM, Zitvogel L, Chaput N (2016) Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC. Onco Targets Ther 5(4):e1071008

    Google Scholar 

  • Bushweller JH (2019) Targeting transcription factors in cancer - from undruggable to reality. Nat Rev Cancer 19(11):611–624

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cha JM, Shin EK, Sung JH, Moon GJ, Kim EH, Cho YH, Park HD, Bae H, Kim J, Bang OY (2018) Efficient scalable production of therapeutic microvesicles derived from human mesenchymal stem cells. Sci Rep 8(1):1171

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Chaput N, Schartz NE, Andre F, Taieb J, Novault S, Bonnaventure P, Aubert N, Bernard J, Lemonnier F, Merad M, Adema G, Adams M, Ferrantini M, Carpentier AF, Escudier B, Tursz T, Angevin E, Zitvogel L (2004) Exosomes as potent cell-free peptide-based vaccine. II. Exosomes in CpG adjuvants efficiently prime naive Tc1 lymphocytes leading to tumor rejection. J Immunol 172(4):2137–2146

    Article  CAS  PubMed  Google Scholar 

  • Chen Z, Meng H, Xing G, Chen C, Zhao Y, Jia G, Wang T, Yuan H, Ye C, Zhao F, Chai Z, Zhu C, Fang X, Ma B, Wan L (2006) Acute toxicological effects of copper nanoparticles in vivo. Toxicol Lett 163(2):109–120

    Article  CAS  PubMed  Google Scholar 

  • Cho JA, Yeo DJ, Son HY, Kim HW, Jung DS, Ko JK, Koh JS, Kim YN, Kim CW (2005) Exosomes: a new delivery system for tumor antigens in cancer immunotherapy. Int J Cancer 114(4):613–622

    Article  PubMed  Google Scholar 

  • Costa AP, Xu X, Burgess DJ (2014) Freeze-anneal-thaw cycling of unilamellar liposomes: effect on encapsulation efficiency. Pharm Res 31(1):97–103

    Article  CAS  PubMed  Google Scholar 

  • Cully M (2018) Targeted therapy: tipping the splicing balance to kill cancer cells. Nat Rev Cancer 18(4):209

    Article  CAS  PubMed  Google Scholar 

  • Daassi D, Mahoney KM, Freeman GJ (2020) The importance of exosomal PDL1 in tumour immune evasion. Nat Rev Immunol 20(4):209–215

    Article  CAS  PubMed  Google Scholar 

  • Dai S, Wei D, Wu Z, Zhou X, Wei X, Huang H, Li G (2008) Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer. Mol Ther 16(4):782–790

    Article  CAS  PubMed  Google Scholar 

  • De Jong WH, Borm PJ (2008) Drug delivery and nanoparticles:applications and hazards. Int J Nanomedicine 3(2):133–149

    Article  PubMed  PubMed Central  Google Scholar 

  • Escudier B, Dorval T, Chaput N, Andre F, Caby MP, Novault S, Flament C, Leboulaire C, Borg C, Amigorena S, Boccaccio C, Bonnerot C, Dhellin O, Movassagh M, Piperno S, Robert C, Serra V, Valente N, Le Pecq JB, Spatz A, Lantz O, Tursz T, Angevin E, Zitvogel L (2005) Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial. J Transl Med 3(1):10

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Fonseka P, Liem M, Ozcitti C, Adda CG, Ang CS, Mathivanan S (2019) Exosomes from N-Myc amplified neuroblastoma cells induce migration and confer chemoresistance to non-N-Myc amplified cells: implications of intra-tumour heterogeneity. J Extracell Vesicles 8(1):1597614

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Frydrychowicz M, Kolecka-Bednarczyk A, Madejczyk M, Yasar S, Dworacki G (2015) Exosomes - structure, biogenesis and biological role in non-small-cell lung cancer. Scand J Immunol 81(1):2–10

    Article  CAS  PubMed  Google Scholar 

  • Fuhrmann G, Serio A, Mazo M, Nair R, Stevens MM (2015) Active loading into extracellular vesicles significantly improves the cellular uptake and photodynamic effect of porphyrins. J Control Release 205:35–44

    Article  CAS  PubMed  Google Scholar 

  • Gheinani AH, Vogeli M, Baumgartner U, Vassella E, Draeger A, Burkhard FC, Monastyrskaya K (2018) Improved isolation strategies to increase the yield and purity of human urinary exosomes for biomarker discovery. Sci Rep 8(1):3945

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Gonzalez-Begne M, Lu B, Han X, Hagen FK, Hand AR, Melvin JE, Yates JR (2009) Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT). J Proteome Res 8(3):1304–1314

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Haney MJ, Klyachko NL, Zhaoa YL, Gupta R, Plotnikova EG, He ZJ, Patel T, Piroyan A, Sokolsky M, Kabanov AV, Batrakova EV (2015) Exosomes as drug delivery vehicles for Parkinson's disease therapy. J Control Release 207:18–30

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Harris DA, Patel SH, Gucek M, Hendrix A, Westbroek W, Taraska JW (2015) Exosomes released from breast cancer carcinomas stimulate cell movement. PLoS One 10(3):e0117495

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Kalra H, Drummen GP, Mathivanan S (2016) Focus on extracellular vesicles: introducing the next small big thing. Int J Mol Sci 17(2):170

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Kalra H, Gangoda L, Fonseka P, Chitti SV, Liem M, Keerthikumar S, Samuel M, Boukouris S, Al Saffar H, Collins C, Adda CG, Ang CS, Mathivanan S (2019) Extracellular vesicles containing oncogenic mutant beta-catenin activate Wnt signalling pathway in the recipient cells. J Extracell Vesicles 8(1):1690217

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kamerkar S, LeBleu VS, Sugimoto H, Yang S, Ruivo CF, Melo SA, Lee JJ, Kalluri R (2017) Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature 546(7659):498–503

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Katakowski M, Buller B, Zheng X, Lu Y, Rogers T, Osobamiro O, Shu W, Jiang F, Chopp M (2013) Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth. Cancer Lett 335(1):201–204

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kikuchi T, Akasaki Y, Irie M, Homma S, Abe T, Ohno T (2001) Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells. Cancer Immunol Immunother 50(7):337–344

    Article  CAS  PubMed  Google Scholar 

  • Kim MS, Haney MJ, Zhao Y, Mahajan V, Deygen I, Klyachko NL, Inskoe E, Piroyan A, Sokolsky M, Okolie O, Hingtgen SD, Kabanov AV, Batrakova EV (2016) Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells. Nanomedicine 12(3):655–664

    Article  CAS  PubMed  Google Scholar 

  • Koh E, Lee EJ, Nam GH, Hong Y, Cho E, Yang Y, Kim IS (2017) Exosome-SIRPalpha, a CD47 blockade increases cancer cell phagocytosis. Biomaterials 121:121–129

    Article  CAS  PubMed  Google Scholar 

  • Kolhe R, Hunter M, Liu S, Jadeja RN, Pundkar C, Mondal AK, Mendhe B, Drewry M, Rojiani MV, Liu Y, Isales CM, Guldberg RE, Hamrick MW, Fulzele S (2017) Gender-specific differential expression of exosomal miRNA in synovial fluid of patients with osteoarthritis. Sci Rep 7(1):2029

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Kooijmans SA, Aleza CG, Roffler SR, van Solinge WW, Vader P, Schiffelers RM (2016) Display of GPI-anchored anti-EGFR nanobodies on extracellular vesicles promotes tumour cell targeting. J Extracell Vesicles 5:31053

    Article  PubMed  CAS  Google Scholar 

  • Kowal J, Arras G, Colombo M, Jouve M, Morath JP, Primdal-Bengtson B, Dingli F, Loew D, Tkach M, Thery C (2016) Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes. Proc Natl Acad Sci USA 113(8):E968–E977

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lee HY, Chen CK, Ho CM, Lee SS, Chang CY, Chen KJ, Jou YS (2018) EIF3C-enhanced exosome secretion promotes angiogenesis and tumorigenesis of human hepatocellular carcinoma. Oncotarget 9(17):13193–13205

    Article  PubMed  PubMed Central  Google Scholar 

  • Liang G, Zhu Y, Ali DJ, Tian T, Xu H, Si K, Sun B, Chen B, Xiao Z (2020) Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer. J Nanobiotechnology 18(1):10

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Liu L, Chang S, Sun J, Zhu S, Yin M, Zhu Y, Wang Z, Xu RX (2015) Ultrasound-mediated destruction of paclitaxel and oxygen loaded lipid microbubbles for combination therapy in ovarian cancer xenografts. Cancer Lett 361(1):147–154

    Article  CAS  PubMed  Google Scholar 

  • Lopez-Leal R, Diaz-Viraque F, Catalan RJ, Saquel C, Enright A, Iraola G, Court FA (2020) Schwann cell reprogramming into repair cells increases miRNA-21 expression in exosomes promoting axonal growth. J Cell Sci 133(12):jcs239004

    Article  CAS  PubMed  Google Scholar 

  • Loureiro JA, Ramalho MJ, Pereira MD (2020) Immuno-nanocarriers for brain delivery: limitations from in vitro to preclinical and clinical studies. Nanomedicine 15(6):543–545

    Article  CAS  PubMed  Google Scholar 

  • Luan X, Sansanaphongpricha K, Myers I, Chen HW, Yuan HB, Sun DX (2017) Engineering exosomes as refined biological nanoplatforms for drug delivery. Acta Pharmacol Sin 38(6):754–763

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lunavat TR, Jang SC, Nilsson L, Park HT, Repiska G, Lasser C, Nilsson JA, Gho YS, Lotvall J (2016) RNAi delivery by exosome-mimetic nanovesicles - implications for targeting c-Myc in cancer. Biomaterials 102:231–238

    Article  CAS  PubMed  Google Scholar 

  • Maroto R, Zhao Y, Jamaluddin M, Popov VL, Wang H, Kalubowilage M, Zhang Y, Luisi J, Sun H, Culbertson CT, Bossmann SH, Motamedi M, Brasier AR (2017) Effects of storage temperature on airway exosome integrity for diagnostic and functional analyses. J Extracell Vesicles 6(1):1359478

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Mathivanan S, Lim JW, Tauro BJ, Ji H, Moritz RL, Simpson RJ (2010) Proteomics analysis of A33 immunoaffinity-purified exosomes released from the human colon tumor cell line LIM1215 reveals a tissue-specific protein signature. Mol Cell Proteomics 9(2):197–208

    Article  CAS  PubMed  Google Scholar 

  • Mirza AH, Kaur S, Nielsen LB, Storling J, Yarani R, Roursgaard M, Mathiesen ER, Damm P, Svare J, Mortensen HB, Pociot F (2019) Breast milk-derived extracellular vesicles enriched in exosomes from mothers with type 1 diabetes contain aberrant levels of microRNAs. Front Immunol 10:2543

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Momen-Heravi F, Bala S, Bukong T, Szabo G (2014) Exosome-mediated delivery of functionally active miRNA-155 inhibitor to macrophages. Nanomed Nanotechnol Biol Med 10(7):1517–1527

    Article  CAS  Google Scholar 

  • Morse MA, Garst J, Osada T, Khan S, Hobeika A, Clay TM, Valente N, Shreeniwas R, Sutton MA, Delcayre A, Hsu DH, Le Pecq JB, Lyerly HK (2005) A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer. J Transl Med 3(1):9

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Muller L, Hong CS, Stolz DB, Watkins SC, Whiteside TL (2014) Isolation of biologically-active exosomes from human plasma. J Immunol Methods 411:55–65

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Munagala R, Aqil F, Jeyabalan J, Gupta RC (2016) Bovine milk-derived exosomes for drug delivery. Cancer Lett 371(1):48–61

    Article  CAS  PubMed  Google Scholar 

  • Nordin JZ, Lee Y, Vader P, Mager I, Johansson HJ, Heusermann W, Wiklander OP, Hallbrink M, Seow Y, Bultema JJ, Gilthorpe J, Davies T, Fairchild PJ, Gabrielsson S, Meisner-Kober NC, Lehtio J, Smith CI, Wood MJ, El Andaloussi S (2015) Ultrafiltration with size-exclusion liquid chromatography for high yield isolation of extracellular vesicles preserving intact biophysical and functional properties. Nanomedicine 11(4):879–883

    Article  CAS  PubMed  Google Scholar 

  • Ohno S, Takanashi M, Sudo K, Ueda S, Ishikawa A, Matsuyama N, Fujita K, Mizutani T, Ohgi T, Ochiya T, Gotoh N, Kuroda M (2013) Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells. Mol Ther 21(1):185–191

    Article  CAS  PubMed  Google Scholar 

  • Paolicelli RC, Bergamini G, Rajendran L (2019) Cell-to-cell communication by extracellular vesicles: focus on microglia. Neuroscience 405:148–157

    Article  CAS  PubMed  Google Scholar 

  • Pathan M, Fonseka P, Chitti SV, Kang T, Sanwlani R, Van Deun J, Hendrix A, Mathivanan S (2019) Vesiclepedia 2019: a compendium of RNA, proteins, lipids and metabolites in extracellular vesicles. Nucleic Acids Res 47(D1):D516–D519

    Article  CAS  PubMed  Google Scholar 

  • Pomatto MAC, Bussolati B, D'Antico S, Ghiotto S, Tetta C, Brizzi MF, Camussi G (2019) Improved loading of plasma-derived extracellular vesicles to encapsulate antitumor miRNAs. Mol Ther Methods Clin Dev 13:133–144

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Qi H, Liu C, Long L, Ren Y, Zhang S, Chang X, Qian X, Jia H, Zhao J, Sun J, Hou X, Yuan X, Kang C (2016) Blood exosomes endowed with magnetic and targeting properties for cancer therapy. ACS Nano 10(3):3323–3333

    Article  CAS  PubMed  Google Scholar 

  • Rana S, Yue S, Stadel D, Zoller M (2012) Toward tailored exosomes: the exosomal tetraspanin web contributes to target cell selection. Int J Biochem Cell Biol 44(9):1574–1584

    Article  CAS  PubMed  Google Scholar 

  • Ren R, Sun H, Ma C, Liu J, Wang H (2019) Colon cancer cells secrete exosomes to promote self-proliferation by shortening mitosis duration and activation of STAT3 in a hypoxic environment. Cell Biosci 9:62

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Rivoltini L, Chiodoni C, Squarcina P, Tortoreto M, Villa A, Vergani B, Burdek M, Botti L, Arioli I, Cova A, Mauri G, Vergani E, Bianchi B, Della Mina P, Cantone L, Bollati V, Zaffaroni N, Gianni AM, Colombo MP, Huber V (2016) TNF-related apoptosis-inducing ligand (TRAIL)-armed exosomes deliver proapoptotic signals to tumor site. Clin Cancer Res 22(14):3499–3512

    Article  CAS  PubMed  Google Scholar 

  • Romagnoli GG, Zelante BB, Toniolo PA, Migliori IK, Barbuto JA (2014) Dendritic cell-derived Exosomes may be a tool for cancer immunotherapy by converting tumor cells into immunogenic targets. Front Immunol 5:692

    PubMed  Google Scholar 

  • Sanwlani R, Fonseka P, Chitti SV, Mathivanan S (2020) Milk-derived extracellular vesicles in inter-organism, cross-species communication and drug delivery. Proteomes 8(2):11

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sato YT, Umezaki K, Sawada S, Mukai SA, Sasaki Y, Harada N, Shiku H, Akiyoshi K (2016) Engineering hybrid exosomes by membrane fusion with liposomes. Sci Rep 6:21933

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Schroeder A, Heller DA, Winslow MM, Dahlman JE, Pratt GW, Langer R, Jacks T, Anderson DG (2011) Treating metastatic cancer with nanotechnology. Nat Rev Cancer 12(1):39–50

    Article  PubMed  CAS  Google Scholar 

  • Shimbo K, Miyaki S, Ishitobi H, Kato Y, Kubo T, Shimose S, Ochi M (2014) Exosome-formed synthetic microRNA-143 is transferred to osteosarcoma cells and inhibits their migration. Biochem Biophys Res Commun 445(2):381–387

    Article  CAS  PubMed  Google Scholar 

  • Soltani F, Parhiz H, Mokhtarzadeh A, Ramezani M (2015) Synthetic and biological vesicular nano-carriers designed for gene delivery. Curr Pharm Des 21(42):6214–6235

    Article  CAS  PubMed  Google Scholar 

  • Stickney Z, Losacco J, McDevitt S, Zhang Z, Lu B (2016) Development of exosome surface display technology in living human cells. Biochem Biophys Res Commun 472(1):53–59

    Article  CAS  PubMed  Google Scholar 

  • Sun D, Zhuang X, Xiang X, Liu Y, Zhang S, Liu C, Barnes S, Grizzle W, Miller D, Zhang HG (2010) A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Mol Ther 18(9):1606–1614

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tang K, Zhang Y, Zhang H, Xu P, Liu J, Ma J, Lv M, Li D, Katirai F, Shen GX, Zhang G, Feng ZH, Ye D, Huang B (2012) Delivery of chemotherapeutic drugs in tumour cell-derived microparticles. Nat Commun 3:1282

    Article  PubMed  CAS  Google Scholar 

  • Tauro BJ, Greening DW, Mathias RA, Ji H, Mathivanan S, Scott AM, Simpson RJ (2012) Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes. Methods 56(2):293–304

    Article  CAS  PubMed  Google Scholar 

  • Thery C, Boussac M, Veron P, Ricciardi-Castagnoli P, Raposo G, Garin J, Amigorena S (2001) Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J Immunol 166(12):7309–7318

    Article  CAS  PubMed  Google Scholar 

  • Thery C, Amigorena S, Raposo G, Clayton A (2006) Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol 3:22

    PubMed  Google Scholar 

  • Tian Y, Li S, Song J, Ji T, Zhu M, Anderson GJ, Wei J, Nie G (2014) A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. Biomaterials 35(7):2383–2390

    Article  CAS  PubMed  Google Scholar 

  • Tomihari M, Chung JS, Akiyoshi H, Cruz PD Jr, Ariizumi K (2010) DC-HIL/glycoprotein Nmb promotes growth of melanoma in mice by inhibiting the activation of tumor-reactive T cells. Cancer Res 70(14):5778–5787

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Vader P, Mol EA, Pasterkamp G, Schiffelers RM (2016) Extracellular vesicles for drug delivery. Adv Drug Deliv Rev 106(Pt A):148–156

    Article  CAS  PubMed  Google Scholar 

  • Wahlgren J, Karlson TD, Brisslert M, Sani FV, Telemo E, Sunnerhagen P, Valadi H (2012) Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes. Nucleic Acids Res 40(17):e130

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wahlund CJE, Gucluler G, Hiltbrunner S, Veerman RE, Naslund TI, Gabrielsson S (2017) Exosomes from antigen-pulsed dendritic cells induce stronger antigen-specific immune responses than microvesicles in vivo. Sci Rep 7(1):17095

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Wang L, Xie Y, Ahmed KA, Ahmed S, Sami A, Chibbar R, Xu Q, Kane SE, Hao S, Mulligan SJ, Xiang J (2013) Exosomal pMHC-I complex targets T cell-based vaccine to directly stimulate CTL responses leading to antitumor immunity in transgenic FVBneuN and HLA-A2/HER2 mice and eradicating trastuzumab-resistant tumor in athymic nude mice. Breast Cancer Res Treat 140(2):273–284

    Article  CAS  PubMed  Google Scholar 

  • Wang Q, Ren Y, Mu J, Egilmez NK, Zhuang X, Deng Z, Zhang L, Yan J, Miller D, Zhang HG (2015) Grapefruit-derived nanovectors use an activated leukocyte trafficking pathway to deliver therapeutic agents to inflammatory tumor sites. Cancer Res 75(12):2520–2529

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wang F, Li L, Piontek K, Sakaguchi M, Selaru FM (2018) Exosome miR-335 as a novel therapeutic strategy in hepatocellular carcinoma. Hepatology 67(3):940–954

    Article  CAS  PubMed  Google Scholar 

  • Watson DC, Bayik D, Srivatsan A, Bergamaschi C, Valentin A, Niu G, Bear J, Monninger M, Sun M, Morales-Kastresana A, Jones JC, Felber BK, Chen X, Gursel I, Pavlakis GN (2016) Efficient production and enhanced tumor delivery of engineered extracellular vesicles. Biomaterials 105:195–205

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wolfers J, Lozier A, Raposo G, Regnault A, Thery C, Masurier C, Flament C, Pouzieux S, Faure F, Tursz T, Angevin E, Amigorena S, Zitvogel L (2001) Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med 7(3):297–303

    Article  CAS  PubMed  Google Scholar 

  • Xie YF, Bai O, Zhang HF, Yuan JY, Zong S, Chibbar R, Slattery K, Qureshi M, Wei YD, Deng YL, Xiang J (2010) Membrane-bound HSP70-engineered myeloma cell-derived exosomes stimulate more efficient CD8(+) CTL- and NK-mediated antitumour immunity than exosomes released from heat-shocked tumour cells expressing cytoplasmic HSP70. J Cell Mol Med 14(11):2655–2666

    Article  CAS  PubMed  Google Scholar 

  • Yaddanapudi K, Meng S, Whitt AG, Al Rayyan N, Richie J, Tu A, Eaton JW, Li C (2019) Exosomes from GM-CSF expressing embryonic stem cells are an effective prophylactic vaccine for cancer prevention. Onco Targets Ther 8(3):1561119

    Google Scholar 

  • Yan IK, Shukla N, Borrelli DA, Patel T (2018) Use of a hollow Fiber bioreactor to collect extracellular vesicles from cells in culture. Methods Mol Biol 1740:35–41

    Article  CAS  PubMed  Google Scholar 

  • Yang T, Martin P, Fogarty B, Brown A, Schurman K, Phipps R, Yin VP, Lockman P, Bai S (2015) Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio rerio. Pharm Res 32(6):2003–2014

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yang Z, Shi J, Xie J, Wang Y, Sun J, Liu T, Zhao Y, Zhao X, Wang X, Ma Y, Malkoc V, Chiang C, Deng W, Chen Y, Fu Y, Kwak KJ, Fan Y, Kang C, Yin C, Rhee J, Bertani P, Otero J, Lu W, Yun K, Lee AS, Jiang W, Teng L, Kim BYS, Lee LJ (2020a) Large-scale generation of functional mRNA-encapsulating exosomes via cellular nanoporation. Nat Biomed Eng 4(1):69–83

    Article  CAS  PubMed  Google Scholar 

  • Yang D, Zhang W, Zhang H, Zhang F, Chen L, Ma L, Larcher LM, Chen S, Liu N, Zhao Q, Tran PHL, Chen C, Veedu RN, Wang T (2020b) Progress, opportunity, and perspective on exosome isolation - efforts for efficient exosome-based theranostics. Theranostics 10(8):3684–3707

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zaborowski MP, Balaj L, Breakefield XO, Lai CP (2015) Extracellular vesicles: composition, biological relevance, and methods of study. Bioscience 65(8):783–797

    Article  PubMed  PubMed Central  Google Scholar 

  • Zhang Q, Liu RX, Chan KW, Hu J, Zhang J, Wei L, Tan H, Yang X, Liu H (2019) Exosomal transfer of p-STAT3 promotes acquired 5-FU resistance in colorectal cancer cells. J Exp Clin Cancer Res 38(1):320

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Zhao L, Gu C, Gan Y, Shao L, Chen H, Zhu H (2020) Exosome-mediated siRNA delivery to suppress postoperative breast cancer metastasis. J Control Release 318:1–15

    Article  CAS  PubMed  Google Scholar 

  • Zomer A, Maynard C, Verweij FJ, Kamermans A, Schafer R, Beerling E, Schiffelers RM, de Wit E, Berenguer J, Ellenbroek SIJ, Wurdinger T, Pegtel DM, van Rheenen J (2015) Vivo imaging reveals extracellular vesicle-mediated phenocopying of metastatic behavior. Cell 161(5):1046–1057

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Victoria, Australia

    Christina Nedeva & Suresh Mathivanan

Authors
  1. Christina Nedeva
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Suresh Mathivanan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christina Nedeva .

Editor information

Editors and Affiliations

  1. Department of Biochemistry and Genetics La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC, Australia

    Suresh Mathivanan

  2. Department of Biochemistry and Genetics La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC, Australia

    Pamali Fonseka

  3. Department of Biochemistry and Genetics La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC, Australia

    Christina Nedeva

  4. Department of Biochemistry and Genetics La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC, Australia

    Ishara Atukorala

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Nedeva, C., Mathivanan, S. (2021). Engineering Extracellular Vesicles for Cancer Therapy. In: Mathivanan, S., Fonseka, P., Nedeva, C., Atukorala, I. (eds) New Frontiers: Extracellular Vesicles. Subcellular Biochemistry, vol 97. Springer, Cham. https://doi.org/10.1007/978-3-030-67171-6_14

Download citation

Publish with us

Policies and ethics

Search

Navigation